Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy
- PMID: 20824868
- PMCID: PMC4033758
- DOI: 10.1002/14651858.CD007855.pub2
Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy
Abstract
Background: Asymptomatic bacteriuria occurs in 5% to 10% of pregnancies and, if left untreated, can lead to serious complications.
Objectives: To assess which antibiotic is most effective and least harmful as initial treatment for asymptomatic bacteriuria in pregnancy.
Search strategy: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (March 2010) and reference lists of retrieved studies.
Selection criteria: Randomized controlled trials comparing two antibiotic regimens for treating asymptomatic bacteriuria.
Data collection and analysis: Review authors independently screened the studies for inclusion and extracted data.
Main results: We included five studies involving 1140 women with asymptomatic bacteriuria. We did not perform meta-analysis; each trial examined different antibiotic regimens and so we were not able to pool results. In a study comparing a single dose of fosfomycin trometamol 3 g with a five-day course of cefuroxime, there was no significant difference in persistent infection (risk ratio (RR) 1.36, 95% confidence interval (CI) 0.24 to 7.75), shift to other antibiotics (RR 0.08, 95% CI 0.00 to 1.45), or in allergy or pruritus (RR 2.73, 95% CI 0.11 to 65.24). A comparison of seven-day courses of 400 mg pivmecillinam versus 500 mg ampicillin, both given four times daily, showed no significant difference in persistent infection at two weeks or recurrent infection, but there was an increase in vomiting (RR 4.57, 95% CI 1.40 to 14.90) and women were more likely to stop treatment early with pivmecillinam (RR 8.82, 95% CI 1.16 to 66.95). When cephalexin 1 g versus Miraxid(R) (pivmecillinam 200 mg and pivampicillin 250 mg) were given twice-daily for three days, there was no significant difference in persistent or recurrent infection. A one- versus seven-day course of nitrofurantoin resulted in more persistent infection with the shorter course (RR 1.76, 95% CI 1.29 to 2.40), but no significant difference in symptomatic infection at two weeks, nausea, or preterm birth. Comparing cycloserine with sulphadimidine, no significant differences in symptomatic, persistent, or recurrent infections were noted.
Authors' conclusions: We cannot draw any definite conclusion on the most effective and safest antibiotic regimen for the initial treatment of asymptomatic bacteriuria in pregnancy. One study showed advantages with a longer course of nitrofurantoin, and another showed better tolerability with ampicillin compared with pivmecillinam; otherwise, there was no significant difference demonstrated between groups treated with different antibiotics. Given this lack of conclusive evidence, it may be useful for clinicians to consider factors such as cost, local availability and side effects in the selection of the best treatment option.
Figures
References
References to studies included in this review
-
- Bayrak O, Cimentepe E, Inegol I, Atmaca AF, Duvan CI, Koc A, et al. Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy? International Urogynecology Journal. 2007;18(5):525–9. - PubMed
-
- Bint A, Bullock D, Reeves D, Wilkinson P. A comparative trial of pivmecillinam and ampicillin in bacteriuria of pregnancy. Infection. 1979;7:290–3. - PubMed
-
- Lumbiganon P, Villar J, Laopaiboon M, Widmer M, Thinkhamrop J, Carroli G, et al. One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. Obstetrics & Gynecology. 2009;113(2 Pt 1):339–45. - PubMed
-
- Robertson JG, Livingstone JRB, Isdale MH. The management and complications of asymptomatic bacteriuria in pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth. 1968;75:59–65. - PubMed
References to studies excluded from this review
-
- Brumfitt W, Pursell R. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women. Journal of Infectious Diseases. 1973;128(Suppl):S657–S663. - PubMed
- Brumfitt W, Pursell R. Trimethoprim-sulphamethoxazole in the treatment of urinary infection. Medical Journal of Australia Special Supplement. 1973;1:44–8. - PubMed
-
- Brumfitt W, Hamilton-Miller JM, Franklin IN, Anderson FM, Brown GM. Conventional and two-dose amoxycillin treatment of bacteriuria in pregnancy and recurrent bacteriuria: a comparative study. Journal of Antimicrobial Chemotherapy. 1982;10:239–48. - PubMed
-
- Christopher LJ, Thompson GR. A trial of hippramine in the treatment of bacteriuria of pregnancy. Irish Journal of Medical Science. 1969;2(7):331–7. - PubMed
-
- Davies BI, Mummery RV, Brumfitt W. Ampicillin, carbenicillin indanyl ester, and nifuratel in the treatment of urinary infection in domiciliary practice. British Journal of Urology. 1975;47:335–41. - PubMed
-
- De Cecco L, Ragni N. Urinary tract infections in pregnancy: monuril single-dose treatment vs traditional therapy. European Urology. 1987;13:108–13. - PubMed
Additional references
-
- Anderson BL, Simhan HN, Simons KM, Wiesenfeld HC. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. American Journal of Obstetrics and Gynecology. 2007;196(6):524.e1–524.e5. - PubMed
-
- Chapman ST. Prescribing in pregnancy. Bacterial infections in pregnancy. Clinics in Obstetrics and Gynaecology. 1986;13(2):397–416. - PubMed
-
- Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? Journal of Antimicrobial Chemotherapy. 2000;46(Suppl 1):29–34. - PubMed
-
- Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. BMJ Books; London: 2001.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical